Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases
Distinguishing clinical subtypes of IBD is critical for optimal treatments, outcome prediction, and better understanding of disease pathogenesis. Here the authors phenotype blood and intestinal immune cells by mass cytometry and identify signatures associated with distinct disease states.
Guardado en:
Autores principales: | Samuel J. S. Rubin, Lawrence Bai, Yeneneh Haileselassie, Gotzone Garay, Chohee Yun, Laren Becker, Sarah E. Streett, Sidhartha R. Sinha, Aida Habtezion |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a229a7519d7425b9121ac0a514fa771 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoprofiling of Drosophila Hemocytes by Single-cell Mass Cytometry
por: József Á. Balog, et al.
Publicado: (2021) -
Rapid monoisotopic cisplatin based barcoding for multiplexed mass cytometry
por: Ryan L. McCarthy, et al.
Publicado: (2017) -
Extended live-cell barcoding approach for multiplexed mass cytometry
por: Muharrem Muftuoglu, et al.
Publicado: (2021) -
Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications
por: John M. Astle, et al.
Publicado: (2021) -
CellCycleTRACER accounts for cell cycle and volume in mass cytometry data
por: Maria Anna Rapsomaniki, et al.
Publicado: (2018)